» Articles » PMID: 36771326

-(-)-Oleocanthal Ex Vivo Modulatory Effects on Gut Microbiota

Overview
Journal Nutrients
Date 2023 Feb 11
PMID 36771326
Authors
Affiliations
Soon will be listed here.
Abstract

Compelling evidence points to the critical role of bioactive extra-virgin olive oil (EVOO) phenolics and gut microbiota (GM) interplay, but reliable models for studying the consequences thereof remain to be developed. Herein, we report an optimized ex vivo fecal anaerobic fermentation model to study the modulation of GM by the most bioactive EVOO phenolic -(-)-oleocanthal (OC), and impacts therefrom, focusing on OC biotransformation in the gut. This model will also be applicable for characterization of GM interactions with other EVOO phenolics, and moreover, for a broadly diverse range of bioactive natural products. The fecal fermentation media and time, and mouse type and gender, were the major factors varied and optimized to provide better understanding of GM-OC interplay. A novel resin entrapment technique (solid-phase extraction) served to selectively entrap OC metabolites, degradation products, and any remaining fraction of OC while excluding interfering complex fecal medium constituents. The effects of OC on GM compositions were investigated via shallow shotgun DNA sequencing. Robust metabolome analyses identified GM bacterial species selectively altered (population numbers/fraction) by OC. Finally, the topmost OC-affected gut bacterial species of the studied mice were compared with those known to be extant in humans and distributions of these bacteria at different human body sites. OC intake caused significant quantitative and qualitative changes to mice GM, which was also comparable with human GM. Results clearly highlight the potential positive health outcomes of OC as a prospective nutraceutical.

Citing Articles

Evaluation of synbiotic combinations of commercial probiotic strains with different prebiotics in in vitro and ex vivo human gut microcosm model.

Raval S, Archana G Arch Microbiol. 2024; 206(7):315.

PMID: 38904672 DOI: 10.1007/s00203-024-04030-3.

References
1.
Clarke E, Taylor L, Zhao C, Connell A, Lee J, Fett B . Sunbeam: an extensible pipeline for analyzing metagenomic sequencing experiments. Microbiome. 2019; 7(1):46. PMC: 6429786. DOI: 10.1186/s40168-019-0658-x. View

2.
Iglesias-Aguirre C, Cortes-Martin A, Avila-Galvez M, Gimenez-Bastida J, Selma M, Gonzalez-Sarrias A . Main drivers of (poly)phenol effects on human health: metabolite production and/or gut microbiota-associated metabotypes?. Food Funct. 2021; 12(21):10324-10355. DOI: 10.1039/d1fo02033a. View

3.
van de Steeg E, Schuren F, Obach R, van Woudenbergh C, Walker G, Heerikhuisen M . An Ex Vivo Fermentation Screening Platform to Study Drug Metabolism by Human Gut Microbiota. Drug Metab Dispos. 2018; 46(11):1596-1607. DOI: 10.1124/dmd.118.081026. View

4.
Kim C, Kelly W, Patchett M, Tannock G, Jordens Z, Stoklosinski H . Monoglobus pectinilyticus gen. nov., sp. nov., a pectinolytic bacterium isolated from human faeces. Int J Syst Evol Microbiol. 2017; 67(12):4992-4998. DOI: 10.1099/ijsem.0.002395. View

5.
Rajakovich L, Balskus E . Metabolic functions of the human gut microbiota: the role of metalloenzymes. Nat Prod Rep. 2018; 36(4):593-625. PMC: 7771511. DOI: 10.1039/c8np00074c. View